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Abstract
Objective
We investigated the nature and neural foundations of pathologic tearfulness in a uniquely large
cohort of patients who had presented with autoimmune limbic encephalitis (aLE).
Methods
We recruited 38 patients (26 men, 12 women; median age 63.06 years; interquartile range
[IQR] 16.06 years) in the postacute phase of aLE who completed questionnaires probing
emotion regulation. All patients underwent structural/functional MRI postacutely, along with
67 age- and sex-matched healthy controls (40 men, 27 women; median age 64.70 years; IQR
19.87 years). We investigated correlations of questionnaire scores with demographic, clinical,
neuropsychological, and brain imaging data across patients. We also compared patients di-
agnosed with pathologic tearfulness and those without, along with healthy controls, on gray
matter volume, resting-state functional connectivity, and activity.
Results
Pathologic tearfulness was reported by 50% of the patients, while no patient reported patho-
logic laughing. It was not associated with depression, impulsiveness, memory impairment,
executive dysfunction in the postacute phase, or amygdalar abnormalities in the acute phase. It
correlated with changes in specific emotional brain networks: volume reduction in the right
anterior hippocampus, left fusiform gyrus, and cerebellum, abnormal hippocampal resting-state
functional connectivity with the posteromedial cortex and right middle frontal gyrus, and
abnormal hemodynamic activity in the left fusiform gyrus, right inferior parietal lobule, and
ventral pons.
Conclusions
Pathologic tearfulness is common following aLE, is not a manifestation of other neuropsy-
chiatric features, and reflects abnormalities in networks of emotion regulation beyond the acute
hippocampal focus. The condition, which may also be present in other neurologic disorders,
provides novel insights into the neural basis of affective control and its dysfunction in disease.
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Most neurologic research on emotion dysregulation focuses
on pseudobulbar affect, which occurs in a broad range of
disorders with diffuse or poorly characterized pathology1–5
often implicating the brainstem and cerebellum.1,6–8 The fact
that pseudobulbar affect has not been associated with focal
limbic damage is consistent with its being understood as “a
disorder of emotional expression rather than a primary dis-
turbance of feelings.”7
Autoimmune limbic encephalitis (aLE) is associated with
the subacute onset of amnesia and seizures and high T2-
signal (acute MRI) in the limbic system, especially the
hippocampus. Patients often respond satisfactorily to
immunosuppressive therapy,9 although many develop hip-
pocampal atrophy and residual cognitive impairment.10,11
While behavioral/psychiatric symptoms may occur
acutely,12 persisting problems with readily provoked tear-
fulness are only mentioned in passing,13–15 and we have
encountered complaints of such symptoms among many of
our patients.
We aimed to determine the so far unexplored nature and
neural correlates of pathologic tearfulness following aLE in
a uniquely large cohort of patients (n = 38). We investigated
its relationships with demographic and clinical data, self-
reported measures of emotion regulation, and performance
on neuropsychological tests. We hypothesized that it is as-
sociated with abnormalities in the hippocampus, the amyg-
dala, hippocampal-diencephalic-cingulate networks, and
cerebro-ponto-cerebellar loops: aLE results in relatively fo-
cal hippocampal atrophy,11,16 and the limbic system is in-
volved in emotion processing.17–19 Amygdala abnormalities
are sometimes observed20 and have been associated with
abnormal autonomic arousal.21 Furthermore, the hippo-
campus is embedded within broader hippocampal-
diencephalic-cingulate networks supporting emotion
regulation.22 We have recently shown abnormalities in this
extended circuitry in aLE.23,24 Finally, in a prominent
pathophysiologic account, emotion dysregulation in pseu-
dobulbar affect was caused by disruption to cerebro-ponto-
cerebellar pathways,7 with which the hippocampus
communicates.25
Methods
Standard protocol approvals, registrations,
and patient consents
Ethical approval was received from the South Central Oxford
Research Ethics Committee (REC no. 08/H0606/133). All
participants provided written informed consent according to
the Declaration of Helsinki.
Participants
We report data relating to pathologic tearfulness in 38
patients with aLE (26 male, 12 female; median age at research
MRI 63.06 years; interquartile range [IQR] 16.16 years)24
after the acute stage of the disease (median 5.41; IQR
5.36 years since symptom onset). All patients were fluent in
English (37 native speakers; 1 non-native speaker) and had
undergone MRI at the time of initial clinical presentation as
well as neuropsychological assessment at the Russell Cairns
Unit, Oxford, UK (2013–2018).
All patients had been diagnosed with aLE according to
established diagnostic criteria26: (a) subacute symptom onset
suggesting involvement of the limbic system; (b) bilateral
abnormalities restricted within the medial temporal lobes
(MTLs) on T2-weighted MRI; (c) CSF pleocytosis (white
blood cells >5/mm3) or slow-wave/epileptic activity in-
volving the temporal cortex (EEG); (d) exclusion of alter-
native causes (e.g., CNS infections/drug toxicity/stroke/
Creutzfeldt-Jakob disease/Kleine-Levin syndrome,
mitochondrial/neoplastic/epileptic/rheumatologic disorders,
septic/metabolic encephalopathy); (e) antibodies against
cell-surface/synaptic/onconeural proteins. Criteria (a–d) are
required for a diagnosis of definite limbic encephalitis, unless,
in the absence of one of (a–c), criterion (e) is satisfied.26
A total of 34 of 38 patients satisfied the criteria for a diagnosis
of definite aLE; the remaining 4/38 had been diagnosed with
aLE, meeting criteria (a, b, d), but not (e). No data could be
recovered regarding (c). In 28/38 patients, an aLE-associated
autoantibody was identified. A total of 10/38 patients dem-
onstrated the clinical profile of aLE with no identified anti-
body; such cases are well-recognized27 and are generally
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thought to involve antibodies not detected in clinical practice
at the time of screening. No patient presented with positive
PCR testing for herpes simplex virus or with anti-NMDAR
encephalitis.28 Two of 38 patients had neoplastic lesions,
thought to be the triggers for their autoimmune disorder,
which were treated and were in full remission at the time of
study participation. A total of 31/38 patients had been treated
acutely with immunotherapy (e.g., plasma exchange, IV or
oral prednisolone). A total of 34/38 patients had shown ab-
normal hippocampal signal, volume, or diffusion on clinical
MRI conducted acutely. Six of 38 patients showed amygdala
abnormalities, 1 in the parahippocampal cortex, 1 in the
entorhinal cortex, 4 patients had mild microangiopathic
changes in keeping with their age, and 1 patient showed extra-
MTL abnormalities (bright caudate). No acute abnormalities
were detected in 4/38 patients, who nonetheless demon-
strated clinical features characteristic of aLE; 35/38 patients
had presented acutely with seizures.
Moreover, patients had no history of previous neurologic or
psychiatric disorder that could have resulted in cognitive
impairment. They were assessed by a single neurologist
(CRB) prior to study inclusion. Their (acute) clinical and
(postacute) neuropsychological details have been presented
previously.24 Healthy controls (HCs) were recruited through
the Oxford Project to Investigate Memory and Ageing (OP-
TIMA) and through local advertisement.
Neuropsychological profile
Postacutely, all patients and 57 HCs (38 men, 19 women; age
at assessment: median, 61.50; IQR 17.26 years; HCs vs
patients: male:female ratio: χ2 = 0.032, p = 0.858; age at
assessment: U = 933.50, p = 0.258) underwent neuro-
psychological assessment. Patients showed preserved execu-
tive function, above-average premorbid intelligence, and
spared motor, executive, and visuospatial function, but im-
paired episodic memory.24
Review of medical records
Details were extracted from medical records and interviews
with the patients and caregivers using a standard proforma
regarding clinical history, acute aLE presentation, and sub-
sequent clinical course of each patient (age at symptom onset;
presenting symptoms; premorbid and acute phase depression,
anxiety, agitation, obsessionality, or hallucinations; seizure
occurrence/recency; delay between symptom onset and
start of treatment; autoantibody type; past/present
immunotherapy, antiepileptics, and antidepressants).
Emotion regulation assessment
Questionnaires
In order to assess patients’ pathologic tearfulness, we ad-
ministered the Center for Neurologic Study–Lability Scale
(CNS-LS),29 a 7-item questionnaire comprising 2 subscales
(“labile crying” and “labile laughter”). A series of additional
questionnaires were administered to examine the relationship
of patients’ pathologic tearfulness with (1) anxiety and de-
pression (Hospital Anxiety and Depression Scale [HADS]),30
(2) impulsivity (Barratt Impulsiveness Scale [BIS]),31 (3)
irritability (Irritability Questionnaire [IRQ]),32 and (4) em-
pathy (Cambridge Behaviour Scale [CBS]33; docs.autismre-
searchcentre.com/tests/EQ40_ScoringKey.doc). A total of
25/38 patients and 29/57 HCs completed and returned those
self-administered questionnaires by post. Patients filled out
the questionnaires together with their next of kin or family
members. Patients who completed the emotion regulation
questionnaires did not differ from those who did not in the
following: (1) neuropsychological tests in which patients
showed preserved group-level performance24 (all ps, pcorr
≥0.340); (2) tests in which patients showed group-level im-
pairment24 (all ps, pcorr ≥0.304); (3) clinical/demographic
variables (see previous section; all ps, pcorr ≥0.999);
(4) volumes of manually delineated MTL structures and
automatically delineated subcortical structures in which there
was no group-level atrophy24 (all ps, pcorr ≥0.209); and (5)
structural/functional brain abnormalities identified at group
level24 (all ps, pcorr ≥0.260).
We also assessed the relationship of patients’ emotion regu-
lation with their memory by conducting bivariate correlation
analyses between memory test scores and scores on ques-
tionnaires of emotion regulation in which patients showed
impairment compared with HCs.
Self-report (clinical interview)
In a complementary approach, and since the CNS-LSmay not
be sensitive to the symptoms described by our patients, we
dichotomized the cohort according to clinical complaint at
interview. The interviewer was blind to patients’ responses in
the above questionnaires. Patients and their family members
were asked whether there had been instances of “labile
laughter” or labile crying, and to provide examples from their
daily life.
Relationship with demographic, clinical, and
neuropsychological profiles
We conducted (1) bivariate correlations of CNS-LS scores
with continuous variables and independent-samples com-
parisons on CNS-LS scores for binary variables across
patients; and (2) comparisons among HCs, patients with, and
patients without pathologic tearfulness (independent-samples
comparisons for continuous variables, χ2 tests for binary
variables).
Brain imaging
Structural MRI
We acquired 3D T1-weighted images using a magnetization-
prepared rapid gradient echo sequence (echo time 4.7 ms,
repetition time 2,040 ms, 8° flip angle, field of view 192 mm,
voxel size 1 × 1 × 1 mm). All 38 patients (26 male, 12 female;
age at imaging: median 63.06; IQR 16.06 years) underwent
structural brain imaging, along with 67 HCs (35 recruited by
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the Memory and Amnesia Project [MAP]; 32 datasets were
made available through OPTIMA; 40 male, 27 female; age at
imaging: median 64.70; IQR 19.87 years; HCs vs patients: M:
F ratio: χ2 = 0.79, p = 0.374; age at imaging: U = 1,239.5;
p = 0.825) (methods also in reference 24).
Volumetry
MTL structures (left/right hippocampus, amygdala, tempor-
opolar, entorhinal, perirhinal, and parahippocampal cortices)
were manually delineated in native space (protocol: ndcn.ox.
ac.uk/files/research/segmentation_protocol_medial_tem-
poral_lobes.pdf).23,24 Subcortical structures (brainstem, left/
right thalamus, caudate nucleus, putamen, pallidum, nucleus
accumbens) were automatically delineated using FSL-FIRST
(v.6.0; https://fsl.fmrib.ox.ac.uk/fsl/fslwiki).34
Whole-brain voxel-based morphometry (VBM)
In order to identify gray matter (GM) volume reduction in
our patient group at a whole-brain level, the T1-weighted
MRIs were analyzed with VBM, conducted using Statistical
Parametric Mapping software (SPM12; fil.ion.ucl.ac.uk/
spm/software/spm12) in MATLAB R2017b. Images were
examined for scanner artefacts and reoriented to have the
same point of origin (anterior commissure) and spatial
orientation. They were then bias-corrected to remove in-
tensity nonuniformities, and segmented into GM, white
matter (WM), and CSF with the unified segmentation
procedure. The diffeomorphic anatomical registration
through the exponentiated lie algebra (DARTEL) toolbox
was applied to participants’ GM, WM, and CSF to refine
intersubject registration, and study-specific GM templates
were generated.35 After affine registration of the GM
DARTEL templates to the tissue probability maps in
Montreal Neurologic Institute (MNI) space, nonlinear
warping of GM images was performed to this template in
MNI space. Voxel values in the tissue maps were modulated
by the Jacobian determinant (calculated during spatial
normalization), with modulated GM images reflecting tissue
volume. These images (voxel size: 1 mm3 isotropic) were
smoothed using a Gaussian filter of 8 mm full width at half
maximum (FWHM). We compared GM volume between
groups (HCs > patients; between-subject covariates: age,
sex, total intracranial volume [TIV], study [MAP, OP-
TIMA]). We report clusters surviving family-wise error
(FWE) correction (p < 0.05) at peak voxel level over
p < 0.001 (uncorrected), as well as clusters surviving cor-
rection for nonstationary smoothness36 and FWE correction
for cluster size (p < 0.05).
Volumes (calculated from manual/automated segmentation,
or the volume reflected by each VBM cluster) that showed
reduction in patients at whole-group level were residualized
against age, sex, TIV, and study and entered in bivariate
correlation analyses with scores in questionnaires of emotion
regulation. We also contrasted patients with pathologic tear-
fulness with those without and HCs across all volumes de-
lineated as well as across the whole brain (VBM).
Resting-state fMRI (rsfMRI)
Whole-brain blood oxygenation level–dependent (BOLD)–
weighted fMRI data were acquired (gradient echo echoplanar
imaging (EPI) sequence; 180 volumes; slice thickness
3.5 mm, echo time 28 ms, repetition time 2,410 ms, 89° flip
angle, field of view 192 mm, voxel size 3 × 3 × 3.5 mm).
Participants were instructed to lie still, not to fall asleep, to
keep their eyes open, and to watch a fixation cross presented
on the in-scanner projector. A total of 35 of 38 patients (3
datasets discarded due to acquisition errors or movement; 24
men, 11 women; median age at imaging, 61.45; IQR 15.85
years) underwent rsfMRI, along with 32 HCs (3 datasets
discarded due to movement or acquisition errors; only
structural MRIs were available for the HCs that were made
available through OPTIMA; 23 men, 9 women; median age
55.71; IQR 17.18 years; HCs vs patients: male:female ratio: χ2
= 0.087; p = 0.768; age at imaging: U = 425.00; p = 0.091).
Preprocessing
EPIs were spatially realigned and slice time–corrected.
Structural MRIs were coregistered to the EPIs, segmented
and normalized along with EPIs in MNI space, followed by
motion outlier detection (artifact detection tools–based
scrubbing). Denoising, including the anatomical component-
based correction method (CompCor), was employed to
remove sources of noise in the BOLD time series data,
deriving principal components from WM and CSF. WM,
CSF, and the 6 movement measures were included as first-
level nuisance covariates. A temporal bandpass filter (0.01–0.1
Hz) was applied to this residual BOLD signal, in order to
remove motion artefacts and physiologic and other artefactual
effects. Images were smoothed using a Gaussian filter
(8 mm FWHM).
Resting-state amplitude of low frequency
fluctuations and functional connectivity
We further examined whether resting-state abnormalities in
the local amplitude of low-frequency fluctuations (rsALFF)
and hippocampal functional connectivity (rsFC) were asso-
ciated with pathologic tearfulness. Preprocessing, rsALFF,
and rsFC analyses were conducted using the CONN toolbox
v. 18.a (nitrc.org/projects/conn).37
rsFC: connectome–multivariate pattern analysis
(MVPA)
In order to identify seed regions for post hoc seed-to-voxel
connectivity analyses in a data-driven fashion, we used MVPA
as implemented in the connectome-MVPA CONN toolbox.
MVPA assesses the multivariate pattern of pairwise con-
nections between voxels across the entire brain by means of
a principal component analysis (PCA) separately for each
voxel that characterizes its rsFC with the rest of the brain. In
the first PCA step, separately for each participant, a default
number of 64 PCA components were retained while charac-
terizing each participant’s voxel-to-voxel correlation structure.
The resulting component scores were stored as first-level
voxel-to-voxel covariance matrices for each participant. In the
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second PCA step, separately for each voxel and jointly across
participants, the 7 strongest components were retained from
a PCA decomposition of the between-subjects variability in
seed-to-voxel connectivity maps between this voxel and the
rest of the brain, according to a conventionally employed ratio
of 1:10 between the number of components extracted and the
number of participants (n = 67). Second-level analyses were
then conducted in order to test for group differences in whole-
brain connectivity (F test across all MVPA components),
comparing for each voxel the component scores between the
2 groups (HCs < > patients; between-subjects covariates: age,
sex). The results for each voxel reflected between-group dif-
ferences in rsFC between this voxel and the rest of the brain.
rsFC: seed-to-voxel connectivity analysis
We followed up the MVPA with post hoc analyses to de-
termine specific connectivity patterns. We thus conducted
a whole-brain seed-to-voxel analysis, seeding from the regions
identified from the MVPA contrast (HCs < > patients), in
order to assess connectivity between those regions and the
rest of the brain.
Resting-state hemodynamic activity: rsALFF
Along with rsFC, we also examined local abnormalities in the
intensity of slow spontaneous fluctuations of hemodynamic
activity at rest across the whole brain, using an analysis of
rsALFF, that is, the total power within the frequency range
between 0.01 and 0.1 Hz, indexing the strength of low-
frequency oscillations.
All the rsfMRI analyses involved age and sex as between-
subjects covariates. Statistical parametrical connectivity maps
were thresholded at a voxel level of p < 0.001 and FWE-
corrected (p < 0.05) at cluster or peak level.
The mean values in clusters of reduced rsALFF or rsFC in
patients at whole-group level, as compared with HCs, were
residualized against age and sex across participants and then
entered in bivariate correlations with scores in questionnaires
of emotion regulation. We also contrasted patients with
pathologic tearfulness against the rest of the patients and HCs
across the whole brain.
Statistical analysis
Statistical (nonimaging) analyses were conducted using SPSS
(v. 25.0, SPSS Inc., Chicago, IL). Significance values were
corrected for multiple testing with the Holm-Bonferroni se-
quential correction method (pcorr). We used the Levene test
to assess variance homogeneity and the Shapiro-Wilk test to
assess normal distribution. When normal distribution was
violated (and log-transformation did not suffice), non-
parametric tests were employed. Parametric (Student or
Welch t tests) and nonparametric tests (Mann-Whitney U)
were used appropriately for independent-samples compar-
isons. For comparisons among 3 groups, univariate analyses of
variance (ANOVAs) or Kruskal-Wallis H tests were used
appropriately, and post hoc comparisons between groups
were Bonferroni-corrected. Pearson r and Spearman ρ were
used appropriately to examine correlations between ques-
tionnaire scores and other measures of interest. We used
multiple stepwise linear regression analysis (default α level of
0.05 for entry to model and 0.1 for removal) to assess the
proportion of the variance of patients’ scores (questionnaires
on emotion regulation) that could be explained by brain
abnormalities.
Data availability
The deidentified data will be available and shared by request
for purposes of replicating procedures and results.
Results
Emotion regulation assessment
Questionnaires: patients vs HCs
Patients scored higher than HCs for labile crying (CNS-LS)
(t = −2.79, pcorr = 0.049) but not for laughter (t = 0.44,
pcorr >0.999; 2-way mixed-effects ANOVA: group: F = 2.49, p
= 0.12; emotion: F = 1.81, p = 0.19; group × emotion:
F = 5.73, p = 0.02). They did not differ from HCs in their
empathy quotient (CBS) (t = 0.79, pcorr >0.999), in irritability
(IRQ) (frequency: U = 235, pcorr = 0.450; intensity:
U = 240.5, pcorr = 0.450), or anxiety (HADS: U = 517,
pcorr = 0.090). They scored higher in the planning (t = −4.97,
pcorr <0.0005) and attention facets (t = −3.90, pcorr = 0.002),
but not in the motor facet for impulsiveness (BIS) (t = 0.38,
pcorr >0.999). They also scored higher for depression
(HADS) (U = 357.5, pcorr < 0.0005), although no patient
scored within the severe range (also noted in reference 24).
Scores for labile crying did not correlate across patients with
impulsiveness (attention and planning facets: ρ = 0.12,
p = 0.60), depression (ρ = 0.24, p = 0.28), or any memory
score in which patients had shown impaired performance as
compared with HCs (all ps, pcorr ≥0.240), and were not as-
sociated with any demographic or clinical variables examined
(all ps, pcorr ≥0.440).
Self-report: patients with vs patients without
pathologic tearfulness and HCs
In a research-oriented clinical interview, 19 of 38 patients
were identified as presenting with pathologic tearfulness. In
particular, they reported being moved to tears easily by rela-
tively minor stimuli in a manner at odds with their premorbid
state (table 1). The other 19 reported never having experi-
enced such instances. No patient reported experiencing epi-
sodes of labile laughter.
The majority of patients and their family members reported
specific triggers of such reactions, including sad stories on the
news and witnessing other people crying (table 2).
Patients with pathologic tearfulness did not differ from the
rest of the participants in any demographic or clinical details
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or in episodic memory impairment, depression, or impul-
siveness. Moreover, they did not differ from the rest of the
patients or HCs in premorbid intelligence, vocabulary, se-
mantic knowledge, visuomotor function or executive
function, anxiety, empathy, or irritability. Among all the tests
and questionnaires administered, the only one in which they
scored differently from both the rest of the patients and HCs
was CNS-LS (table 3).
Table 1 Patients’ self-reports
Pathologic tearfulness
“Since diagnosis I feel far more emotional within myself.”
“I’ve turned into a bit of a wimp. Overwhelmed by emotion.”
Triggers of pathologic tearfulness
“The news or other information [or] stories with which I have no personal connection.”
“Articles on the radio [or] TV, newspapers, situations that I don’t have control over.”
“Children being successful […], overcoming […] handicap.”
“When my cat brings me a ’present’ e.g., a mouse, [a] bird.”
Examples of the self-reports of pathologic tearfulness and triggers of pathologic tearfulness that patients with autoimmune limbic encephalitis provided to
a neurologist (C.R.B.) during their research-oriented clinical interview postacutely. Each line represents a different patient’s perspective.
Table 2 Triggers of pathologic tearfulness as identified by patients and their family members
Patient code
(see
reference 24
for further
details)
Sad stories on
television/
newspaper/radio
(e.g., children
suffering) Music
Animals
(suffering or
acting
affectionately)
Other
people
crying
Events involving
family members
(e.g., death,
departure,
progress,
overcoming
hardship)
Unfamiliar
environment
Photographs
of marriage
No mention
of trigger
1 +
2 +
5 +
9 + +
10 +
11 +
12 +
13 +
14 + +
15 + +
17 + +
25 +
26 + +
27 +
29 +
30 +
33 +
34 +
38 + +
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Table 3 Neuropsychological, clinical, and demographic profile of patients with vs patients without pathologic tearfulness vs healthy controls (HCs)
Domain Test
Subtest (max
score/z)
HCs Tearful2 Tearful+
Comparison among
groups Post hoc comparisons
M IQR M IQR M IQR Value pcorr
a
HCs vs
tearful2
Tearful+ vs
HCs
Tearful+ vs
tearful2
Neuropsychological profile (tearful vs nontearful patients vs HCs)
Mood, personality, and emotion CNS-LS “Labile crying” (15) 4.0 2.0 4.0 4.0 7.0 4.0 F 9.19 0.016 >0.999 <0.0005 0.011
“Labile laughter” (20) 6.0 5.0 5.5 5.0 5.0 4.0 F 0.15 >0.999
BIS Planning (44) 20.0 6.0 26.0 7.3 26.0 7.0 F 12.76 0.002 <0.0005 0.003 >0.999
Attention (32) 13.0 3.5 17.5 8.3 15.0 1.9 F 8.40 0.020 0.001 0.049 0.711
Motor (44) 21.0 4.5 21.5 8.1 19.5 4.5 F 1.09 >0.999
HADS Depression (21) 1.0 2.3 3.0 8.0 2.0 4.0 H 16.69 0.019 0.015 0.001 >0.999
Anxiety (21) 4.0 4.0 4.5 7.0 7.0 2.0 H 7.80 0.340
IRQ Frequency (63) 13.5 9.0 15.0 18.5 17.0 8.8 H 3.40 >0.999
Intensity (63) 17.5 11.3 17.0 20.8 21.0 12.0 H 2.60 >0.999
CBS EQ (80) 45.0 11.5 43.5 14.4 42.4 25.3 F 0.33 >0.999
Intelligence, semantic memory,
and language
GNT (z) 0.8 1.1 0.4 2.4 −0.1 1.0 H 10.74 0.110
WASI/WASI-II Vocabulary (z) 1.4 1.3 0.4 1.6 0.9 1.5 F 6.43 0.072
NART p-FSIQ (z) 1.5 0.8 0.9 1.2 1.1 0.8 H 8.41 0.285
WASI/WASI-II Similarities (z) 1.1 0.8 0.7 1.1 0.9 0.7 H 7.13 0.392
C&CT (z) 0.3 1.2 0.0 1.7 0.0 1.0 H 5.57 0.806
AMI Personal
Semantics
Remote: childhood
(21)
19.5 3.0 18.0 4.1 16.5 5.0 Η 7.43 0.360
Remote: early
adulthood (21)
20.5 2.0 20.5 3.3 19.0 2.0 Η 10.48 0.110
Episodic memory
Autobiographical AMI
Autobiographical
Remote: childhood
(9)
9.0 3.0 5.0 4.8 4.0 4.0 Η
17.34
0.019 0.001 0.002 >0.999
Remote: early
adulthood (9)
9.0 1.5 5.5 6.0 4.0 4.0 Η
24.81
0.019 0.001 0.0005 >0.999
Continued
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Table 3 Neuropsychological, clinical, and demographic profile of patients with vs patients without pathologic tearfulness vs healthy controls (HCs) (continued)
Domain Test
Subtest (max
score/z)
HCs Tearful2 Tearful+
Comparison among
groups Post hoc comparisons
M IQR M IQR M IQR Value pcorr
a
HCs vs
tearful2
Tearful+ vs
HCs
Tearful+ vs
tearful2
Neuropsychological profile (tearful vs nontearful patients vs HCs)
Verbal recall WMS-III Logical Memory I (z) 0.3 1.9 −1.3 1.1 −1.0 1.7 F 24.34 <0.0005 <0.0005 <0.0005 0.464
Logical Memory II (z) 0.7 1.7 −2.5 1.3 −0.7 2.0 H 43.48 0.019 <0.0005 <0.0005 0.674
Word List I (z) 0.7 1.8 −1.2 1.3 −0.7 1.3 H 36.44 0.019 <0.0005 0.001 0.201
Word List II (z) 1.3 1.0 −1.0 1.5 −0.7 2.3 H 32.68 0.019 <0.0005 <0.0005 >0.999
D&P People (z) −0.3 1.6 −1.3 1.0 −1.3 1.2 H 20.40 0.019 <0.0005 0.002 >0.999
Verbal recognition WMS-III Word List II
Recognition (z)
0.7 1.0 −1.7 2.4 0.3 1.7 H 31.09 0.019 <0.0005 0.14 0.007
RMT Words (z) 1.0 1.5 −0.3 2.2 0.3 2.0 H 19.13 0.019 <0.0005 0.004 >0.999
D&P Names (z) 0.3 2.0 −0.8 2.3 −1.2 1.6 F 13.88 <0.0005 0.002 <0.0005 0.872
Visual recall ROCFT Immediate Recall (z) 1.3 1.9 −1.4 2.9 0.0 2.6 H 26.36 0.019 <0.0005 0.013 0.29
Delayed Recall (z) 1.3 2.0 −2.2 2.8 −0.4 3.5 H 24.76 0.019 <0.0005 0.013 0.385
D&P Shapes (z) 0.7 1.0 −1.0 2.5 −0.7 2.2 F 18.31 <0.0005 <0.0005 <0.0005 >0.999
Visual recognition D&P Doors (z) 0.7 1.3 −1.0 1.3 −0.2 1.5 H 14.77 0.025 0.001 0.166 0.443
RMT Scenes (z) 1.0 1.0 −0.1 2.4 −0.6 3.0 F 12.50 0.001 0.0004 0.0005 >0.999
Faces (z) 0.0 2.3 −0.5 1.7 −0.3 2.4 F 0.80 >0.999
Verbal forgetting D&P Verbal Forgetting (z) 0.7 1.0 −0.3 2.0 −0.5 2.5 H 8.94 0.220
Visual forgetting Visual Forgetting (z) 0.3 0.0 0.3 2.3 0.3 1.7 H 11.42 0.072
Executive function DKEFS Trails Number–Letter
Switching (z)
0.7 0.7 0.3 1.8 0.3 0.7 H 7.59 0.352
WMS-III Digit Span (z) 1.0 1.2 0.0 1.7 0.3 1.4 F 4.42 0.285
Visuomotor function ROCFT Copy (%iles) >16th
%ile
— >16th
%ile
— >16th
%ile
— H 3.60 >0.999
DKEFS Trails Visual Scanning (z) 0.7 1.5 0.3 1.3 0.0 1.3 H 2.48 >0.999
Motor Speed (z) 0.7 1.0 0.3 1.3 0.3 2.7 H 5.22 0.876
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Table 3 Neuropsychological, clinical, and demographic profile of patients with vs patients without pathologic tearfulness vs healthy controls (HCs) (continued)
Domain Test
Subtest (max
score/z)
HCs Tearful2 Tearful+
Comparison among
groups Post hoc comparisons
M IQR M IQR M IQR Value pcorr
a
HCs vs
tearful2
Tearful+ vs
HCs
Tearful+ vs
tearful2
Neuropsychological profile (tearful vs nontearful patients vs HCs)
VOSP Cube Analysis (10) 10.0 1.0 9.0 2.0 9.5 1.3 H 4.88 0.957
Position
Discrimination (20)
20.0 0.3 20.0 1.0 20.0 0.0 H 2.21 >0.999
Dot Counting (10) 10.0 0.0 10.0 0.0 10.0 0.0 H 1.63 >0.999
Measure
Tearful2 Tearful+ Tearful+ vs 2
M IQR M IQR Value pcorr
a
Demographic and clinical profile (tearful vs nontearful patients)
Age at structural MRI, y 65.3 14.9 57.4 18.1 U 163.00 >0.99
Symptom onset to treatment onset delay, wk 12.0 31.0 8.0 15.0 U 144.00 >0.99
Age at symptom onset, y 58.6 11.1 52.7 20.0 t 0.774 >0.99
Symptom onset to research scan delay, y 4.0 4.0 5.7 7.5 t −1.09 >0.99
Age at neuropsychological assessment, y 64.0 13.0 60.0 18.1 t 0.20 >0.99
Sex, M:F 13:6 13:6 χ2 0.00 >0.99
Premorbid depression 1+:18− 2+:17− χ2 0.36 >0.99
Seizures
Recency (last seizure > vs <1 year since research scan date) 10>:6< 8>:11< χ2 1.45 >0.99
Acute clinical T2 MRI abnormalities
HPC (+ vs 2) 16+:3− 18+:1− χ2 1.12 >0.99
AMG (+ vs 2) 5+:14− 1+:18− χ2 3.17 >0.99
Acute symptoms
Depression (+ vs 2) 6+:13− 6+:13− χ2 0.00 >0.99
Anxiety (+ vs 2) 7+:12− 9+:10− χ2 0.43 >0.99
Agitation (+ vs 2) 7+:12− 11+:8− χ2 1.69 >0.99
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Table 3 Neuropsychological, clinical, and demographic profile of patients with vs patients without pathologic tearfulness vs healthy controls (HCs) (continued)
Measure
Tearful2 Tearful+ Tearful+ vs 2
M IQR M IQR Value pcorr
a
Hallucinations 2+:17− 7+:12− χ2 3.64 >0.99
Obsessionality 4+:15− 3+:16− χ2 0.18 >0.99
Autoantibodies
Seropositive (+ vs 2) 13+:6− 15+:4− χ2 0.54 >0.99
LG1 (+ vs 2) 8+:11− 10+:9− χ2 0.42 >0.99
Immunotherapy
Oral (+ vs 2) 12+:7− 17+:2− χ2 3.64 >0.99
PLEX (+ vs 2) 6+:13− 5+:14− χ2 0.13 >0.99
IVIg (+ vs 2) 12+:7− 13+:6− χ2 0.12 >0.99
Medication
BZD (+ vs 2) 2+:17− 2+:17− χ2 0.00 >0.99
SSRI (+ vs 2) 6+:13− 6+:13− χ2 0.00 >0.99
AED (+ vs 2) 14+:5− 17+:2− χ2 1.58 >0.99
Abbreviations: AED = antiepileptic drugs; AMG = amygdala; AMI = Autobiographical Memory Interview (scores for participants aged 50 or older were only analyzed, as those pertained to remote memories up to participants’
mid 30s; AMI scores are not age-scaled); BIS = Barratt Impulsiveness Scale; BZD = benzodiazepines; C&CT = Camel and Cactus Test; CBS = Cambridge Behavior Scale; CNS-LS = Center for Neurologic Study–Lability Scale (scores
were log-transformed); D&P = Doors and People Test; DKEFS = Delis-Kaplan Executive Function System; EQ = empathy quotient; F = univariate analysis of variance; GNT = Graded Naming Test; H = Kruskal-Wallis H; HADS =
Hospital Anxiety and Depression Scale; HC = healthy controls; HPC = hippocampus; IQR = interquartile range; IRQ = Irritability Questionnaire; IVIg = IV immunoglobulin; LGI1 = anti-leucine-rich glioma-inactivated 1 (the most
prominent autoantibody identified in our cohort); M =median; NART = National Adult Reading Test; pFSIQ = premorbid Full-Scale Intelligence Quotient; PLEX = plasma exchange; RMT =Warrington Recognition Memory Tests
(words, faces) and Warrington Topographical Memory test (scenes); ROCFT = Rey-Osterrieth Complex Figure Test; SSRI = selective serotonin reuptake inhibitor; VOSP = Visual Object and Space Perception Battery; WASI =
Wechsler Abbreviated Scales of Intelligence; WMS-III = Wechsler Memory Scale III.
Post hoc comparisons per univariate analysis of variance/Kruskal-Wallis H tests are Bonferroni-corrected.
a pcorr = p values corrected using the Holm-Bonferroni sequential correction for multiple comparisons, separately for neuropsychologic and demographic/clinical variables.
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Structure/function–Behavior relationships
Questionnaires: correlations with CNS-LS and BIS
scores
In our previous study,24 we identified a series of brain ab-
normalities (n = 13) that patients showed at group level:
volume reduction in the left and right hippocampus, captured
by both VBM and manual delineation; volume reduction in
the anterior-mediodorsal thalamus and right dorsolateral
thalamus (VBM) and the left thalamus (automated de-
lineation), as well as the right entorhinal cortex (manual
delineation); reduced right hippocampal rsFC with left hip-
pocampus, ventral-posterior posteromedial cortex (posterior
cingulate, retrosplenial cortex, and precuneus; Brodmann area
[BA] 23, 31), and medial prefrontal cortex (BA 10, 32, 24);
and reduced rsALFF in the posterior cingulate and the pre-
cuneus (BA 23, 31). We entered the mean values of the
clusters that reflected these abnormalities (residualized
against age and sex for functional abnormalities, as well as TIV
and study [MAP, OPTIMA] for volumes) in bivariate cor-
relations with CNS-LS scores for labile crying. Patients’ scores
correlated strongly with their reduced right hippocampal
rsFC with the ventral-posterior posteromedial cortex (r =
−0.61, pcorr = 0.030; rest of ps, pcorr ≥0.190; figure 1A). No
such correlations were identified with impulsivity (BIS at-
tention and planning facets) or depression (HADS) scores,
even at uncorrected levels (|r| <0.29, p > 0.18).
Moreover, given our a priori hypotheses on the role of the
hippocampus in emotion dysregulation, we examined, at
uncorrected levels, correlations with CNS-LS scores. Right
anterior hippocampal volume correlated negatively across
patients with scores for labile crying (r = −0.52, p = 0.01; left
anterior, right/left posterior hippocampus: p > 0.07; figure
1B), but not with right hippocampal rsFC with the poster-
omedial cortex (r = 0.33, p = 0.05). When these 2 factors
were entered as independent variables in a multiple stepwise
linear regression, the analysis was terminated in 2 steps, with
the right hippocampal–posteromedial cortical rsFC included
in the first model as a predictor of patients’ scores of labile
crying (F = 12.50, p = 0.002; R2 = 0.37), and with the volume
of the right anterior hippocampus entered in the model in
the second step (F = 9.55, p = 0.001; R2 = 0.49). No volu-
metric correlation of any hippocampal segment was identi-
fied with impulsivity or depression scores (|r| <0.25,
p > 0.19).
Self-report: patients with vs without
pathologic tearfulness and HCs
Structural abnormalities
Patients with pathologic tearfulness did not differ from the
rest of the patients in anyMTL or subcortical volumes (pcorr ≥
0.350). Nevertheless, a whole-brain VBM analysis disclosed
lower volume for these patients relative to the other 2 groups
in the right anterior hippocampus, the right cerebellar hemi-
spheric HVI/HVIIa Crus I, and the left fusiform gyrus (BA
37; figure 2).
Functional abnormalities
A connectome–MVPA analysis on rsFC across the whole
brain identified a cluster in the right hippocampus as a region
in which patients with pathologic tearfulness differed from the
other 2 groups. We thus seeded from the right hippocampus
in native space (unsmoothed timeseries), in order to identify
regions with which these patients showed abnormal right
hippocampal rsFC: they showed aberrantly increased right
hippocampal rsFC with the right middle frontal gyrus (BA 9)
Figure 1 “Labile crying” scores in patients with autoimmune limbic encephalitis: structure/function–behavior relationships
Bivariate correlations between Cen-
ter for Neurologic Study–Lability
Scale (CNS-LS) scores for labile crying
(log-transformed) and measures of
structural and functional abnormali-
ties. (A) Correlation with mean rest-
ing-state functional connectivity
(rsFC) between the right hippocam-
pus (HPC) and posteromedial cortex
(PMC). (B) Correlation with volume of
the (manually delineated) right ante-
rior HPC (head). Red = right HPC
head; yellow = right HPC body; teal =
right HPC tail; green = left HPC head;
blue = left HPC body; pink = left HPC
tail. R, L = right, left (hemisphere); z-
res = volumes are residualized
against age, sex, total intracranial
volume, and study (Memory and
Amnesia Project, Oxford Project to
Investigate Memory and Ageing)
across participants; mean rsFC val-
ues are residualized against age and
sex across participants.
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and reduced rsFCwith a region in the right posterior cingulate
extending to the precuneus and lingual gyrus (BA 23, 18).
Patients with pathologic tearfulness also showed aberrantly
increased rsALFF in the left fusiform gyrus (BA 37) and the
ventral pons, as well as reduced rsALFF in the right inferior
parietal lobule (BA 39; figure 3).
Discussion
Our study is the first to investigate the nature and neural
foundations of emotion dysregulation in a uniquely large,
homogeneous cohort of patients after aLE, a nondegenerative
neurologic syndrome characterized by primary limbic
pathology.
Clinical features and correlates of
emotion dysregulation
In particular, we describe a novel disorder of emotion regu-
lation following aLE that is characterized by residual patho-
logic tearfulness. In our cohort, this was reported by 50%
of patients. This symptom may be misdiagnosed as a mani-
festation of depression; for example, an indirect consequence
of reduced quality of life due to memory impairment. If
present alongside disinhibition and impulsiveness, it may
otherwise be interpreted as a sign of a broader dysexecutive
syndrome, continuous with that sometimes present in the
acute stage of aLE.10 However, we showed that pathologic
tearfulness was not associated with depression or impulsive-
ness, and occurred in the face of preserved executive function,
and at normal levels of anxiety and irritability. Notably, no
clinical or behavioral difference was detected between the
patients with pathologic tearfulness and the equally sized
subset with no such symptoms, apart from their scores on
labile crying (CNS-LS).
To our knowledge, this symptom has only been mentioned in
passing in case or case series studies of aLE13–15 or in studies
of larger yet less homogeneous cohorts of autoimmune en-
cephalitis or epilepsy,38,39 as “emotional lability,” “mood la-
bility,” or “uncharacteristic tearfulness,” with no further
discussion of its clinical features and correlates. Direct com-
parisons with other patient groups such as temporal lobe
epilepsy will be needed in future studies. Moreover, the profile
of pathologic tearfulness observed in our patients with aLE is
strikingly different from the syndrome of pseudobulbar affect
seen in other neurologic conditions (e.g., amyotrophic lateral
sclerosis, stroke, multiple sclerosis, Parkinson disease, Alz-
heimer disease, and traumatic brain injury1–5), where dra-
matic and debilitating bouts of laughing or crying occur often
without any appropriately valanced trigger7 or congruence
between the experience and expression of emotion.40 For
instance, none of our patients presented with pathologic
laughing. Furthermore, most patients who presented with
pathologic tearfulness readily identified specific triggers that
were congruent with their albeit exaggerated emotional
Figure 2 Structural abnormalities in patients with pathologic tearfulness
Results ofwhole-brain voxel-basedmorphometry (VBM) onmodulated graymatter (GM) (reflectingGMvolume). Contrast: healthy controls (HCs) andpatients
without pathologic tearfulness > patients with pathologic tearfulness; between-subjects nuisance regressors: age, sex, total intracranial volume (TIV), and
study (Memory and Amnesia Project [MAP], Oxford Project To Investigate Memory and Ageing [OPTIMA]). (A) Right anterior hippocampus: kE = 19, p family-
wise error-corrected (FWE) = 0.037; peak voxel: t = 4.79; x = 34, y = −12, z = −17. (B) Left fusiform gyrus/posterior portion of inferior temporal gyrus: kE = 17; p
FWE= 0.038; peak voxel: t = 4.79; x = −44, y = −62, z = −5. (C) Right cerebellar hemispheric lobules VI/VIIa Crus I: kE = 23; p FWE= 0.042; peak voxel: t = 4.76; x = 24,
y = −75, z = −18; clusters are displayed here at p < 0.001 (unc) for display purposes, and survive FWE correction (p < 0.05) at peak-voxel level over p < 0.001 (unc)
(minimum cluster volume: kE > 10). The cerebellar cluster also survived correction for nonstationary smoothness and cluster size (p-FWE < 0.05). Clusters are
overlaid here on a diffeomorphic anatomical registration through exponentiated lie algebra GM template in Montreal Neurological Institute space (sagittal
sections presented); heat bar represents t values; bar graphs display the average GM volume of each of those 3 clusters for the 3 different groups; error bars
represent +1/−1 SEM. aHPC = anterior hippocampus; FG = fusiform gyrus; ITG = inferior temporal gyrus; kE = cluster size (number of voxels); R, L = right, left
(hemisphere); z-res = mean values residualized against age, sex, study (MAP, OPTIMA), and TIV across participants.
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responses. Many of these triggers pertained to situations that
evoked empathic concern (e.g., children or animals in distress
or acting affectionately). This may suggest that aberrantly in-
creased empathy underlies the patients’ symptoms. There are,
indeed, strong links between empathy and proneness to crying
in the healthy population, which may suggest that increased
empathy is associated with increased likelihood to experience
distress, resulting in a higher crying proneness (see reference
41). Whereas the CBS did not disclose abnormality in patients
with pathologic tearfulness, it may lack sensitivity in capturing
increased, rather than decreased, empathy. Likewise, while the
CNS-LS represents the most broadly employed self-report
measure of affective lability,29 more targeted instruments need
to be employed, examining autonomic responses within the
context of finer-grained behavioral tasks. This might lead to
identification of similar symptoms in other neurologic dis-
orders, such as temporal lobe epilepsy, where suggestive evi-
dence has already been presented.42
Structural and functional correlates
In line with our hypotheses, we found correlates of pathologic
tearfulness in the anterior hippocampus, the posterior cin-
gulate cortex, the ventral pons, and the neocerebellum.
Whether these abnormalities result directly from the acute,
primary pathology of aLE or occur subsequently as a form of
functional diaschisis or as a consequence of Wallerian de-
generation23 remains to be determined (see also discussion in
reference 12). Figure 4 summarizes the insight our study
provides on the impairments underlying pathologic tearful-
ness in aLE, based on the model in reference 7.
Anterior hippocampal volume
Right anterior hippocampal atrophy was associated with
pathologic tearfulness. The right anterior hippocampal vol-
ume correlated across patients with scores for labile crying
(CNS-LS), and patients with pathologic tearfulness showed
less volume in the right anterior hippocampus in a voxel-wise
Figure 3 Functional abnormalities in patients with pathologic tearfulness
(A) A connectome–multivariate pattern analysis demonstrated that patientswith pathologic tearfulness, as comparedwith the rest of the patients andhealthy
controls (HCs), showed abnormal resting-state functional connectivity (rsFC) between a region in the right hippocampal (HPC) head and body and the rest of
the brain; right hippocampal head and body: 24 −16 −14, kE = 194; p family-wise error-corrected (FWE) (cluster-level) = 0.001. (B-C) Patients with pathologic
tearfulness showed (B) increased rsFC of the right hippocampuswith the rightmiddle frontal gyrus (MFG) (x = 36, y = 40, z = 30; kE = 105, p FWE=0.03, t = −4.09),
and (C) reduced rsFC of the right hippocampuswith the posteromedial cortex (PMC) (peak voxel: t = 4.65; x = 18, y = −50, z = 6; kE = 98, p FWE = 0.04), extending
to the right lingual gyrus. (D–F) Patients with pathologic tearfulness showed aberrantly increased resting-state amplitude of low frequency fluctuations
(rsALFF) as comparedwith both the rest of the patients andhealthy controls in (D) the left fusiformgyrus (kE = 69; peak voxel: t = −4.72; x = −50, y = −60, z = −20),
and (E) the ventral pons (kE = 74; peak voxel: t = −5.08; x = −2, y = −20, z = −44; p FWE = 0.04), and reduced rsALFF in (F) the right inferior parietal lobule (peak
voxel: t = 5.84; x = 56, y = −62, z = 40; kE = 112; p FWE = 0.004). All clusters survive FWE correction (p < 0.05) for cluster size over an uncorrected individual voxel
threshold of p < 0.001. Error bars represent ± 1 SEM. FG = fusiform gyrus; IPL = inferior parietal lobule; kE = cluster size; R, L = right, left (hemisphere); z-res =
mean rsFC and rsALFF values are residualized against age and sex across participants.
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whole-brain analysis. That hippocampal lesions should be as-
sociated with pathologic tearfulness is consistent with the in-
volvement of limbic circuitry in emotion processing,17 especially
with the relationship between recurrent stress and hippocampal
damage in nonhuman primates,19 as well as with hippocampal
pathology in psychiatric disorders.43 In particular, the primate
anterior hippocampus is the homologue of the rodent ventral
hippocampus, which plays a role in negative affect, by virtue of
its connectivity with the amygdala and the hypothalamus.18
However, manually delineated hippocampal volumes did not
differ between patients with and those without pathologic
tearfulness, suggesting that atrophy may be confined to specific
regions within the anterior hippocampus, a possibility that could
be explored using subfield volumetry in future studies.
Hippocampal dysconnectivity with the
posteromedial cortex
Scores for labile crying (CNS-LS) strongly correlated with
patients’ reduced right hippocampal rsFC with the ventral
posteromedial cortex (posterior cingulate, retrosplenial cor-
tex, and precuneus). Evidence from functional neuroimaging
of healthy adults supports a role of this region in empathic
concern for emotional suffering and admiring virtue.44 Ab-
errant perspective taking and empathy has also been reported
in hippocampal patients.45,46
Pontocerebellar abnormalities
Volume reduction was also noted for patients with pathologic
tearfulness in posterior portions of the right hemispheric cer-
ebellar lobules VI/VIIa Crus I. These regions are embedded
within the default mode network, which is fundamental for
self-referential cognition.47 The cerebellum receives input
from the basilar pons, and disruption of cortico-ponto-
cerebellar circuits may lower the threshold for emotional ex-
pression.7 Moreover, anatomical and electrophysiologic work
has recently disclosed evidence for cerebellar (lobules VI/VIIa
Crus I)–hippocampal interactions, possibly via the pons.25
Consistent with these accounts, patients with pathologic
tearfulness demonstrated aberrantly increased rsALFF in the
ventral pons. The ventral pons relays input to the cerebellum
from cortical regions including the parietal association corti-
ces,48 where these patients showed reduced right hippocampal
rsFC. Interestingly, pontine hemodynamic hyperactivity has
been reported previously in a single case study of pathologic
laughing,6 consistent with earlier reports of pathologic crying
in cases of pontine myelinosis.8
Abnormalities in the inferior parietal lobule,
fusiform, and middle frontal gyri
Beyond the relationships that we had hypothesized, we also
observed a series of unpredicted abnormalities associated with
pathologic tearfulness: GM volume reduction and aberrantly
increased rsALFF in the left fusiform gyrus, reduced rsALFF
in the right inferior parietal lobule, and reduced rsFC between
the right hippocampus and the right middle frontal gyrus.
While activations in all of these regions have been repeatedly
shown in self-face processing,49,50 the aberrantly increased
rsFC and rsALFF in patients with pathologic tearfulness re-
quire further investigation, as they may reflect compensatory
or maladaptive mechanisms.
Figure 4 Network abnormalities underlying pathologic tearfulness in autoimmune limbic encephalitis (aLE)
Illustration of the network abnormalities that may
underlie pathologic tearfulness following aLE,
based on our findings and on the model of
“pathological laughing and crying” proposed by
Parvizi et al. (2001). The locations mentioned in
the figure are only those identified as abnormal in
this study, and other regions are likely to be in-
volved as well. Blue box = telencephalic sites that
are assumed to process “emotionally competent”
stimuli along with relevant context information
that may include the middle frontal gyrus (MFG),
the posterior ventral posteromedial cortex (PMC),
the inferior parietal lobule (IPL), and the fusiform
gyrus (FG); these act on the induction sites (green
box) (e.g., ventromedial prefrontal cortex, anterior
cingulate, amygdala, ventral striatum), which may
also include the anterior hippocampus (HPC);
these sites detect the stimuli and context, and act
on the effector sites (yellow box) (e.g., motor cor-
tex, hypothalamus, periaqueductal gray, cranial
nerve nuclei), which trigger the emotional re-
sponse. Red arrows = cerebro-ponto-cerebellar
pathways, through which telencephalic areas
convey to the cerebellum information on the
emotionally competent stimuli alongwith context-
related information; blue arrows = the cerebellum
modulates the profile, intensity, and duration of
the emotional responses in accordance with the
context of the triggering stimulus by providing
input to the induction and effector sites; structural
and functional abnormalities in these sites may
trigger emotional responses (pathologic tearful-
ness) that are contextually inappropriate.
Neurology.org/N Neurology | Volume 94, Number 12 | March 24, 2020 e1333
Our study describes a novel disorder of emotion regulation
following aLE that is characterized by residual pathologic
tearfulness, is not related to low mood or cognitive impair-
ment, and is associated with specific abnormalities within
networks supporting emotion regulation. Clinicians need to
be aware of the potential for such symptoms to develop after
aLE and of the distress they can cause. Furthermore, patho-
logic tearfulness offers a useful neuropsychological model for
exploring the neural mechanisms of emotion regulation and
may provide insight into the breakdown of these mechanisms
across a wide range of neurologic conditions. This will inform
the development and refinement of behavioral and pharma-
ceutical interventions.
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